Amanote Research
Register
Sign In
Ebv-Mir-Bhrf1-1 Targets P53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia
Hematological Oncology
- United Kingdom
doi 10.1002/hon.42_2631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
W. Xu
D. Xu
L. Wang
H. Zhu
J. Li
J. Liang
Publisher
Wiley
Related search
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Identification of MEF2B , EBF1 , and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
Frontiers in Oncology
Cancer Research
Oncology
Immunoregulatory Defects and Epstein-Barr Virus (Ebv) in Hemophilia
Pediatric Research
Child Health
Pediatrics
Perinatology
High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients With Chronic Lymphocytic Leukemia Associated With Unfavorable Prognosis
PLoS ONE
Multidisciplinary
Epstein-Barr Virus DNA Load in Chronic Lymphocytic Leukemia Is an Independent Predictor of Clinical Course and Survival
Oncotarget
Oncology
Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica
Hematology